- $2.57bn
- $2.79bn
- $4.21bn
- 94
- 66
- 57
- 84
2019 September 28th | 2020 October 3rd | 2021 October 2nd | 2022 October 1st | 2023 September 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,164 | 3,390 | 3,369 | 3,811 | 4,210 |
Cost of Revenue | |||||
Gross Profit | 292 | 313 | 323 | 347 | 395 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 3,022 | 3,237 | 3,193 | 3,633 | 4,014 |
Operating Profit | 142 | 153 | 176 | 178 | 196 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 126 | 135 | 160 | 158 | 161 |
Provision for Income Taxes | |||||
Net Income After Taxes | 116 | 116 | 139 | 138 | 139 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 109 | 117 | 139 | 138 | 139 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 109 | 117 | 139 | 138 | 139 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.77 | 3.76 | 4.86 | 4.94 | 5.84 |